Medicinova, Inc. (MNOV) Dividend History

Medicinnova, Inc. is a biotechnology company focused on developing novel therapeutics for rare and serious diseases. The company's research primarily targets conditions with limited treatment options, leveraging its expertise in drug discovery and development to bring innovative solutions to unmet medical needs.

4275 Executive Square, La Jolla, CA, 92037
Phone: 858-373-1500
Website: https://www.medicinova.com

Dividend History

Medicinova, Inc. currently does not pay dividends

Company News

  • MediciNova, Inc. announced the enrollment of the first patient in an NIH-funded Expanded Access Program (EAP) trial to evaluate their drug MN-166 for the treatment of amyotrophic lateral sclerosis (ALS).

    GlobeNewswire Inc.
  • Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Destiny Tech100 Inc (NASDAQ: DXYZ) rose 52.9% to $13.76 in pre-market trading after gaining 9% on Tuesday. PaySign, Inc. (NASDAQ: PAYS) gained 25.2% to $4.23 in pre-market trading after the company announced better-than-expected fourth-quarter results. Hitek Global Inc. (NASDAQ: HKIT) gained 19.1% to $1.69 in pre-market trading. The ONE Group Hospitality, Inc. (NASDAQ: STKS) shares rose 13.2% to $4.54 in pre-market trading after the company announced that it will acquire Safflower Holdings. nCino, Inc. (NASDAQ: NCNO) gained 11.7% to $33.72 in pre-market trading as the company reported better-than-expected fourth-quarter results and issued FY25 adjusted earnings guidance above estimates.. Nuvation Bio Inc. (NASDAQ: NUVB) shares rose 11.5% to $3.21 in pre-market trading. Nuvation Bio shares gained 28% on Tuesday after BTIG upgraded the stock from Neutral ...

    Benzinga
  • These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors.

    The Motley Fool
    Featured Companies: AVXL TARS
Page data last updated 07/25/2025 01:33:38 UTC